Moderna seeks to enter Thai vaccine market

Additionally, Indian firm Bharat Biotech has begun the process of submitting the required documentation for registration of its vaccine, senior Food and Drug Administration (FDA) official Surachoke Tangwiwat confirmed.

The Indian company’s vaccine has returned interim efficacy rates of 81% in late-stage clinical trials, it confirmed earlier this month.

As Thailand gears up for its mass vaccination drive, these vaccines would complement those already approved and being offered from Chinese manufacturer Sinovac and British-Swedish firm AstraZeneca. The FDA also confirmed yesterday that it…